Steve Ludbrook

Company: Bicycle Therapeutics

Job title: Director of Molecular Pharmacology

Seminars:

Outlining Safety Advantages for Nectin-4 Relative to EphA2: Potential Benefits of Operating in a Novel Target Space 9:30 am

Discovering the Bicycle Toxin Conjugate and potential applications in a novel target space Outlining potential tolerance of less background activity Discovering toxicological advancements that may lend a hand in novel target applicationsRead more

day: Conference Day One